GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome

Authors

Pilar Alama1, Jose Bellver2, Carmen Vidal1, Juan Giles1,*
1Department of Reproduction, IVI-Valencia, Plaza de la Policia Local, Valencia, Spain
2Department of Paediatrics, Obstetrics and Gynaecology, Faculty of Medicine. University of Valencia, Valencia, Spain
*Corresponding Author: Department of Reproduction, Valencia Infertility Institute, Plaza de la Policia Local 3, Valencia 46015, Spain. Tel: +34-963050900, [email protected]. Email: [email protected]

International Journal of Endocrinology and Metabolism:Vol. 11, issue 2; 107-16
Published online:Mar 31, 2013
Article type:Review Article
Received:Jul 08, 2012
Accepted:Aug 17, 2012
How to Cite:Alama P, Bellver J, Vidal C, Giles J. GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome. Int J Endocrinol Metab. 2013;11(2):. doi: https://doi.org/10.5812/ijem.5034

Abstract

Abstract:

The GnRH analogue (agonist and antagonist GnRH) changed ovarian stimulation. On the one hand, it improved chances of pregnancy to obtain more oocytes and better embryos. This leads to an ovarian hyper-response, which can be complicated by the ovarian hyperstimulation syndrome (OHSS). On the other hand, the GnRH analogue can prevent the incidence of OHSS: GnRH antagonist protocols, GnRH agonist for triggering final oocyte maturation, either together or separately, coasting, and the GnRH analogue may prove useful for avoiding OHSS in high-risk patients. We review these topics in this article.

Full Text

Full text is available in PDF

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

16
Jun
2020

Evaluation of Anti-Mullerian Hormone Predictive Value and Antral Follicle Count in the Success Rate of Ovarian Drilling in Polycystic Ovary Syndrome

Leili Hafizi,
Akram Behrouznia,
Maliheh Amirian,
Mina Baradaran,
Seyedeh Azam Pourhoseini

Hafizi L, Behrouznia A, Amirian M, Baradaran M, Pourhoseini SA. Evaluation of Anti-Mullerian Hormone Predictive Value and Antral Follicle Count in the Success Rate of Ovarian Drilling in Polycystic Ovary Syndrome. Shiraz E-Med J. 2020;21(6):e92162. doi: https://doi.org/10.5812/semj.92162

30
Jun
2006

The relation between third day FSH level and incidence of poor response in patients undergoing ART cycles

M Ashrafi,
A Seirafi Tehranian,
F Malekzadeh

Ashrafi M, Seirafi Tehranian A, Malekzadeh F. The relation between third day FSH level and incidence of poor response in patients undergoing ART cycles. J Inflamm Dis. 2024;10(1):e155201. doi:

21
Feb
2015

Ovarian Drilling Efficacy, Estradiol Levels and Pregnancy Rate in Females With Polycystic Ovary Syndrome

Farideh Moramezi,
Roshan Nikbakhat,
Azam Rafigh

Moramezi F, Nikbakhat R, Rafigh A. Ovarian Drilling Efficacy, Estradiol Levels and Pregnancy Rate in Females With Polycystic Ovary Syndrome. Jentashapir J Cell Mol Biol. 2015;6(1):e27171. doi: https://doi.org/10.5812/jjhr.27171

20
Nov
2010

Ovarian Cysts Formation During Depot Formulation of GnRH-a Therapy and the Effect of Pretreatment with Oral Contraceptive Pills on Subsequent Implantation and Pregnancy Rate in ART Cycles

Zahra Raoofi,
Abbas Aflatoonian

Raoofi Z, Aflatoonian A. Ovarian Cysts Formation During Depot Formulation of GnRH-a Therapy and the Effect of Pretreatment with Oral Contraceptive Pills on Subsequent Implantation and Pregnancy Rate in ART Cycles. Iran J Pharm Res. 2022;7(2):e128578. doi: https://doi.org/10.22037/ijpr.2010.752

27
Jun
2015

Determination of Sex Hormones, Glucose Tolerance Test and Insulin Concentrations in Prediction of Clomiphene Citrate Efficacy in Polycystic Ovary Syndrome

Farideh Moramezi,
Najmieh Sadati,
Zohre Aboutalebi

Moramezi F, Sadati N, Aboutalebi Z. Determination of Sex Hormones, Glucose Tolerance Test and Insulin Concentrations in Prediction of Clomiphene Citrate Efficacy in Polycystic Ovary Syndrome. Jentashapir J Cell Mol Biol. 2015;6(3):e27174. doi: https://doi.org/10.5812/jjhr.27174

More by these authors

Pilar AlamaPubMedScholar
Jose BellverPubMedScholar
Carmen VidalPubMedScholar
Juan GilesPubMedScholar
Share
Cited by
Metrics